| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |